Does amphotericin treat myelodysplastic syndromes?

Amphotericin is a normal cytoprotective agent that is currently used in the treatment of myelodysplastic syndromes.
Amphotericin is a normal cell protector, which is clinically used in the adjuvant treatment of various cancers. As in chemotherapy, chemotherapeutic drugs will also kill normal cells when killing tumor cells, and aminophosine can reduce the killing effect of chemotherapeutic drugs on normal cells.
Amphotericin is mainly used for lung cancer, ovarian cancer, breast cancer, bone tumors, etc. It can also be used for pre-chemotherapy treatment of many kinds of cancers, such as digestive tract tumors, hematological system tumors, etc. It can help to reduce the toxic side effects of chemotherapy drugs.
It should be noted that this drug should be used with caution in patients with low blood pressure and low blood calcium, and is contraindicated in patients with a history of allergy to this product and allergy to mannitol.
Amphotericin should be used under the guidance of a professional doctor after diagnosis and evaluation of the patient’s condition, and should not be used blindly on its own.